All In Biotech

Drug Trial Radar · NCT07698886

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Jul 16, 2026

Primary completion

Aug 15, 2027

Study completion Sep 15, 2027

Sponsor

Lead sponsor
KTH BiopharmaIndustry
Sponsor type
Industry
First posted
Jul 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Conditions

  • HPV (Human Papillomavirus)-Associated
  • Genital Warts

Interventions

  • Geniwa gelDrug

    Geniwa gel contains alpha lactalbumin-oleic acid 5%

  • Placebo gelOther

    Placebo gel contains saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The efficacyTime frame: 12 weeks of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Dermatology Hospital, Hanoi, Vietnam.

    Hanoi, None (International), Vietnam · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.